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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYDuring development, the hematopoietic and vascular lineages are thought to descend from common mesodermal progenitors called
hemangioblasts. Here we identify six transcription factors, Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1, that ‘‘trap’’ murine cells in a pro-
liferative state and endow them with a hemangioblast potential. These ‘‘expandable’’ hemangioblasts (eHBs) are capable, once released
from the control of the ectopic factors, to give rise to functional endothelial cells, multilineage hematopoietic cells, and smooth muscle
cells. The eHBs can be derived from embryonic stem cells, from fetal liver cells, or poorly from fibroblasts. The eHBs reveal a central role
for fibroblast growth factor, which not only promotes their expansion, but also facilitates their ability to give rise to endothelial cells
and leukocytes, but not erythrocytes. This study serves as a demonstration that ephemeral progenitor states can be harnessed in vitro,
enabling the creation of tractable progenitor cell lines.INTRODUCTION
In developing mammals, hematopoiesis initially occurs
extraembryonically, most prominently in the yolk sac
(Silver and Palis, 1997), and later arises within the embryo
in the aorta-gonad-mesonephros (AGM) region (Godin
etal., 1993;Medvinskyetal., 1993) anddevelopingendocar-
dium (Nakano et al., 2013). Definitive hematopoietic stem
cells (HSCs), which are responsible for blood production
throughout life, first detectibly emerge in the AGM (Mu¨ller
et al., 1994) andcolonize the fetal liver (FL), ultimatelyoccu-
pying niches in the bonemarrow (reviewed inMikkola and
Orkin, 2006). The specification of blood is closely coordi-
nated with the specification of blood vessels, and genetic
evidence supports the notion of a shared ontogeny. For
example, murine embryos null for Kdr (also known as
Flk1) do not develop blood islands or blood vessels and die
between embryonic development days 8.5 and 9.5 (Shalaby
et al., 1995). In chimeric embryos, Kdr null cells are not
detected in later sites of hematopoiesis such as the FL or
adult bone marrow but are found in other mesodermal
tissues like heart, kidney, and muscle (Shalaby et al.,
1997). In fact, endothelial cells and hematopoietic cells
can be observed in vitro to arise from the samemesodermal
progenitors, called hemangioblasts (Choi et al., 1998).
Previously, our group has isolated human embryonic
stem cells (ESCs) whose pluripotent state is maintained
in vitro by exogenous growth factor signaling, particularly
fibroblast growth factor (FGF), insulin or insulin-like
growth factor, and transforming growth factor (BendallStem Cell Repet al., 2007; Chen et al., 2011; Thomson et al., 1998; Vallier
et al., 2005; Wang et al., 2007; Xu et al., 2005). These ESCs,
in contrast to their ephemeral progenitor counterparts
in vivo, can be cultured formany generations in the plurip-
otent state—they are fortuitously ‘‘trapped’’ in this state
by the exogenous growth factor signaling, which sustains
the expression of master transcription factors, including
POU5F1, SOX2, and NANOG. These same factors, when
ectopically expressed, can induce somatic cells to adopt a
pluripotent stem (iPS) state (Takahashi et al., 2007; Takaha-
shi and Yamanaka, 2006; Yu et al., 2007). Once iPS cells are
reprogrammed, the ectopic factors are no longer required,
as the endogenous factors can be maintained by the appro-
priate exogenous growth factor signaling.
A concept that thus emerges from these studies is that a
core set of factors is central to both the induction andmain-
tenance of a particular cell state. There are now numerous
examples of inducing a desired cell state by the ectopic
expression of key factors (reviewed in Pereira et al., 2012),
for example, reprogramming fibroblasts to cells with
characteristics of cardiomyocytes or hemogenic endothe-
lium (Ieda et al., 2010; Pereira et al., 2013). In this study,
we did not set out to reprogram cells per se; rather, we set
out to determine the feasibility of employing core factors
to maintain progenitors in culture. We hypothesized
it might be possible to expand progenitor cells—without
a priori knowledge of the exact exogenous signaling
factors required for their maintenance in vitro—merely by
ectopically expressing key genes. We identify six factors,
Gata2, Lmo2,Mycn, Pitx2, Sox17, and Tal1, that collectivelyorts j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 The Authors 1043
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gioblast potential.RESULTS
Identifying Factors that Maintain Hemangioblast
Potential
We screened for factors thatmightmaintain hematopoietic
progenitors in culture by examining candidate genes that
either had literature support for their role in hematopoiesis
(for example, Chambers et al., 2007; Elcheva et al., 2014;
Petriv et al., 2010) and/or were expressed in FL HSCs. The
screen involved electroporating combinations of transcrip-
tion factors and miRNAs encoded on doxycycline induc-
ible cassettes into murine ESCs stably via the PiggyBac
transposase system (Figures 1A and 1B). Electroporated
cells were differentiated on Matrigel, following a previous
established protocol (Chiang and Wong, 2011), to meso-
derm cells, and then doxycycline was added to activate
the ectopic genes as the cells were further differentiated
toward hemogenic endothelium. Four days after the intro-
duction of doxycycline, rare domed colonies formed with
tight, defined edges (Figure 1C, top image). The colonies,
composed of small adherent cells, occurred at a frequency
of 1 to 2 of 1,000 ESCs transfected with a combination of
eight transcription factors and one miRNA, and did not
arise in transfected cell populations in the absence of
doxycycline (Figure 1D, compare first two bars; data not
shown). The domed colonies were observed in multiple
independent ESC lines (Figure 1E, first bar). These colonies
resembled early blast colonies before they differentiate
into both endothelial and hematopoietic cells (Lancrin
et al., 2009), except that they continued to grow without
apparent differentiation.
In the presence of doxycycline, the cells in the domed
colonies were often expandable; that is, the colonies could
be picked under a dissectingmicroscope, gently dissociated
with EDTA, and replated on Matrigel and continue to pro-Figure 1. Screening for Hemangioblasts
(A) Overview of the screening procedure.
(B) Schematic representation of the inducible expression vectors em
(C) An example of domed colonies arising 4 days after induction w
colonies 14 days after induction with doxycycline (bottom image). B
(D) Average colony number ± SD from at least three independent exp
(E) Average colony number ± SD in three independent ES lines.
(F and G) Five domed colonies were pooled from each well and exp
evaluated by FACS. Example FACS dot plots are presented to the left; th
maintained with doxycycline (top graph) or the same isolates devoi
combination of factors, the results are independent experiments fro
markers. (G) Hematopoietic marker employing the same isolates fro
comparing results with those from all nine factors).
Stem Cell Repliferate. The expanding colonies (cultured 11 to 21 days)
tended to lose their domed morphology, forming loose
associations of scattered cells (Figure 1C, bottom image).
When doxycycline was withdrawn from the expanded
populations of cells in N2B27 medium supplemented
with the growth factors BMP4, FGF2, VEGF, and the small
molecules SB431542 and Br-cAMP (vasculogenic mixture
or Vm, following the naming convention used previously;
Chiang andWong, 2011), the cells expressed PECAM1 and
CDH5, surface markers of endothelial cells, at efficiencies
ranging from 21% to 87% (Figure 1F, compare top and bot-
tom graphs, first column). When released from doxycy-
cline and placed in medium supplemented with stem cell
factor (SCF), Wnt agonist CHIR99021, interleukin-3, and
FLT3L (referred to collectively as SCIF), factors that favor
early hematopoiesis (Ruiz-Herguido et al., 2012; Taoudi
et al., 2008), in a hypoxic (1.5% O2) atmosphere, cells
were observed to express the canonical hematopoietic
marker CD45 (Figure 1G, compare top and bottom graphs,
first column). The ability of the isolates to generate CD45+
cells was less efficient and even more variable (1% to 23%
of the population) than the ability of the same isolates
to produce endothelial-like cells, suggesting that the
emergence of the blood cells required a more complex
configuration of ectopic factors to be present in the isolates.
To determine which of the nine factors might be respon-
sible for these phenotypes, dropout experiments were
conducted. Each of these nine factors was removed one at
a time from the combination to determine which were
required for domed colony formation. The removal of
Mycn or Sox17 reduced colony numbers by 4- or 11-fold,
respectively (Figure 1D). Conversely, Mycn and Sox17
together drove the formation of domed colonies in three
independent ES lines with frequencies comparable to cells
transfected with all nine factors (Figure 1E), although the
colony sizes induced by the two factors alone tended to
be smaller (data not shown). Next, to determine which
factor(s) were required for the production of endothelial
or blood cells, additional dropout experiments wereployed.
ith doxycycline (top image). An example of passaged (expanded)
oth images are phase contrast. White bars represent 100 mm.
eriments in one ES line.
anded in Vm containing doxycycline. The resulting isolates were
e box indicates cells considered positive for the marker(s) in isolates
d of doxycycline for the indicated times (bottom graph). For each
m two ES lines with at least one isolate per line. (F) Endothelial
m (F) (*p < 0.05, **p < 0.01, Wilcoxon rank sum test, one sided,
orts j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 The Authors 1045
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An Expandable, Inducible Hemangioblast Stateperformed (Figures 1F and 1G). In these experiments,Mycn
and Sox17were always present in the factor combination to
ensure colony formation. The experiments revealed that
the absence of Tal1 significantly reduced the ability of
the isolates to express endothelial markers upon the with-
drawal of doxycycline (Figure 1F). In addition, the absence
of Lmo2, Pitx2,Gata2, orTal1 significantly reduced the abil-
ity of the isolates to produce CD45+ cells (Figure 1G). These
data together indicated that six transcription factors,
Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1, collectively
imposed a program in cells that (1) trapped them in a pro-
liferative state and (2) endowed them with the potential to
differentiate toward either blood or endothelial fates, once
one or more of the factors was downregulated by the
removal of doxycycline.
Expandable Hemangioblasts Give Rise to Functional
Endothelial Cells, Multilineage Blood Cells,
and Smooth Muscle Cells
Single colonies, now derived with only the six transcrip-
tion factors in independent ES lines, were isolated,
expanded, and cryopreserved. The cells, which we dubbed
‘‘expandable hemangioblasts’’ (eHBs), were confirmed to
express all six factors ectopically (Figure S1A available
online) and then were tested for their ability to differen-
tiate to select cell types once released from the progenitor
state by the withdrawal of doxycycline.
First, cells were cultured in Vm for 3 days. In contrast
to control cells maintained with doxycycline, these cells
dually expressed the endothelial markers PECAM1 and
CDH5 (Figure 2A) and efficiently took up acetylated low-
density lipoprotein (Ac-LDL) (Figure 2B). The cells were
furthermore able to form capillary-like tubular networks
(Figure 2C) with lumen (Figure S1B) when embedded
within Matrigel. Collectively, these data indicate that
eHBs can differentiate into functional endothelial cells.Figure 2. Characterization of the eHBs
(A and B) Endothelial differentiation (3 days). (A) Endothelial markers
293T cells were employed as a negative control. The bar identifies ce
(C) Formation of capillary-like networks in Matrigel. Cells were differen
White bars represent 400 mm.
(D) Hematopoietic differentiation time course. The values represent t
in three independent experiments of the eHB line RB3.6.5.
(E) Erythrocyte differentiation (4 days).
(F) Macrophage differentiation (9 days).
(G) Megakaryocytes/proplatelet differentiation (4 days).
(H) Smooth muscle differentiation (3 days).
All example dot plots, images, and histograms are from the eHB line
single colony) were maintained with doxycycline in Vm or differentiate
dot plots are provided for each assay. The box indicates cells consid
adjacent bar graphs as the average percent of positive cells ± SD fro
histograms are provided for each assay. The bar represents cells consid
as the average percent of cells ± SD from at least three independent
Stem Cell RepThe eHBs were next cultured in medium supplemented
with SCIF in a hypoxic (1.5% O2) atmosphere to induce
hematopoiesis. We employed markers previously used to
trace the ontogeny of hematopoietic populations in early
sites of hematopoiesis, including the yolk sac and AGM
region (Nishikawa et al., 1998; Taoudi et al., 2008) and/or
used to trace the differentiation of hemangioblasts to
hematopoietic cells through an endothelial-like state
(hemogenic endothelium) (Lancrin et al., 2009). In a time-
dependent fashion, the eHBs appeared to give rise to blood
progeny by transiting through an intermediate state in
which the endothelial markers TIE2 or CDH5 were coex-
pressed with the blood markers CD41 or CD45 (Figures 2D
and S1C). The transient CDH5+ cells were able to take up
Ac-LDL (Figure S1D), which supports the notion of their
endothelial-like nature, although their ability to do so was
not as efficient as the eHB-derived endothelial cells (compare
Figures 2B and S1D). To confirm that the blood cells indeed
arose from these putative hemogenic endothelial intermedi-
ates, the differentiating cells were sorted into CDH5+ and
CDH5 populations 2 days into the culture and then
cultured for 2 days further. The CDH5+ cells robustly gave
rise to CD45+ cells, in contrast to their CDH5 counterparts
(Figure S1E). These data indicate that eHBs give rise to blood
cells through an endothelial-like intermediate state, in a
manner consistent with previously described emerging
hematopoietic populations either in vitro or in vivo.
The eHBs were next tested for their ability to produce
hematopoietic cells of different lineages. When placed in
conditions akin to those previously described to promote
erythropoiesis (Sturgeon et al., 2012), the cells gave rise
to TER119+ erythrocytes (many of which were also CD71+;
Figure 2E) that abundantly expressed embryonic hemoglo-
bin, but quite poorly expressed adult hemoglobin (Fig-
ure S1F). This result indicates that the eHBs preferentially
give rise to primitive hematopoiesis. When differentiated. (B) Cells were incubated with fluorescently labeled Ac-LDL for 2 hr;
lls efficiently taking up Ac-LDL.
tiated for 7 days in Vm and then embedded in Matrigel for 10 days.
he average percent of cells in each quadrant ± SD measured by FACS
RB3.6.5. Two independent eHB cell lines (each established from a
d in the absence of doxycycline (‘‘Dox’’). (A and E–G) Example FACS
ered positive for the markers; these values are summarized in the
m three independent experiments of each line. (B and H) Example
ered positive. These values are compiled in the adjacent bar graphs
experiments of each line. See also Figure S1 and Table S1.
orts j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 The Authors 1047
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generate macrophages (Choi et al., 2011), the eHBs pro-
duced CD45+/CD11B+ (Mac-1) macrophages (Figures 2F
and S1G). When differentiated in Stemline II medium
(Sigma) supplemented with SCIF and the megakaryocyte
cytokine TPO, the cells gave rise to megakaryocytes and
proplatelets, as indicated by the dual expression of the
markers CD42D (Takada et al., 1995) and CD41 (Figure 2G)
and the presence of multinucleated cells (Figure S1H).
Finally, when differentiated in medium supplemented
with SCIF, the eHBs also produced, albeit quite inefficiently,
BFU-Es (erythrocyte progenitors), CFU-G/M/GMs (granulo-
cyte and/or macrophage progenitors), and CFU-GEMMs
(granulocyte, erythrocyte, macrophage, and megakaryo-
cyte progenitors) (Figure S1I). Together, these data indicate
the eHBs, when released from control of the ectopic factors,
are capable of undergoing multilineage hematopoiesis.
Next, the eHBs were assayed for their potential to give
rise to smooth muscle cells, a capacity also attributed to
hemangioblasts (Yamashita et al., 2000). After 3 days,
differentiation on collagen IV in conditions previously
shown to promote the differentiation of smooth muscle
cells (Xiao et al., 2007), the eHBs gave rise to progeny (Fig-
ure S1J) that expressed smooth muscle actin (ACTA2) and
the additional smooth muscle markers Cnn1 (calponin 1),
Myh11 (smMHC), and Tagln (Sm22a) (reviewed in Owens,
1995) (Figures 2H and S1K). These data indicate that be-
sides blood and endothelial potential, the eHBs also possess
smooth muscle potential.
Finally, we challenged the eHBs to give rise to cells not
considered to be the progeny of hemangioblasts. The cells
were tested for their ability to produce cardiomyocytes,
which arise from progenitors that are related to hemangio-
blasts, but distinguishable from them (Kattman et al., 2006,
2011). Aggregates of eHBs and their parent ESC lines were
differentiated in conditions based on previous studies
(Sargent et al., 2009; Zhang et al., 2012) designed to pro-
mote cardiomyocyte differentiation. In contrast to the
ESC lines, spontaneously beating cardiomyocytes did not
arise detectibly from the eHBs (Figures S1L and S1M).
Instead, at least some of their surviving progeny appear
to differentiate into smooth muscle cells under these con-
ditions (Figure S1M). Taken together, these data suggest
that when released from the ectopic factors, the eHBs pref-
erentially give rise to blood and vascular lineages, evidence
that supports their putative hemangioblast identity.
To determine how long in culture the six ectopic factors
could maintain the eHB state, two eHB lines were passaged
heavily—approximately 117 population doublings, an
expansion of over 1035 from the founding cells—and
then differentiated into endothelial, blood, or smooth
muscle cells (Figure S1N). Even after this extensive
passaging, both cell lines were still competent to produce1048 Stem Cell Reports j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 Ththe three cell types, but tended to do so with a reduced ef-
ficiency, an effect associated in one line with the silencing
of ectopic Gata2 (Figure S1A).
The Six Factors Can Induce the eHB State
Asdescribed above, the same set of factors thatmaintain the
ES pluripotent state in culture also can induce this state in
somatic cells. Although we had originally identified the
six transcription factors as those that could maintain a he-
mangioblast state, we supposed that these factors might
also induce the state. To test this notion, we transfected
mouse embryonic fibroblasts (MEFs) or embryonic day
14.5 FL cells with the six factors and cultured them in the
presence of doxycycline. The MEFs were employed as a
test of transdifferentiation and the FL cells as a test of
either transdifferentiation or dedifferentiation because the
FL, at this stage, is a hematopoietic organ. Approximately
1 week after transfection, colonies with eHB morphology
emerged from either source, at an observed frequency of
almost 1:1000 transfected cells (Figures 3A and 3B). Three
independent eHB lines expressing the six factors ectopically
(Figure S2A) derived from MEF or FL cells were established
from single colonies and assayed for their ability to give
rise to endothelial (Figures 3C, 3D, S2B, and S2C),
blood (Figures 3E, 3F, S2D, and S2E), and smooth muscle
(Figures 3G and S2F) cells in the absence of doxycycline.
The FL-eHBs were able to produce all three cell types. How-
ever, the MEF-eHBs tended to perform more poorly, parti-
cularly in the production of blood or smooth muscle cells,
indicating that the factors do not fully reprogram MEFs, at
least in the lines examined.
The eHBs derived from cultured cells (ESCs orMEFs) were
often found with missegregations of the Y chromosome,
possessing XYY, XO, or both (Table S1). This result parallels
the previously known instability of the Y chromosome
in cultured murine ESCs (Eggan et al., 2002), except that
here we detect cells not only containing XO, but also the
counterpart XYY. However, all eHBs derived from uncul-
tured FL cells tested so far possess anormal karyotype. These
data indicate that primary cells (or perhaps female cells)
may be the best sources from which to derive the eHBs.
RNA-Seq Analysis of eHBs and Their Derivatives
The eHBs were next analyzed globally by RNA-seq to
further assess their developmental status. We examined
the transcriptomes of lines derived from ESC, FL, or MEF
sources as well as their differentiated progeny and com-
pared them with those of ESCs, ESC-derived KDR+ meso-
derm cells (a population of cells that includes early
hemangioblasts), and primary cell populations enriched
for either embryonic endothelial cells (embryonic day
11.5 PECAM1+/CDH5+ cells dissociated from either the
yolk sac or embryo), or FL HSCs (embryonic day 14.5e Authors
Figure 3. The eHBs Can Be Derived from Different Cell Sources
(A and B) Colonies present 8 days (E14.5 FL cells) or 7 days (MEFs) after transfection. (A) Example phase contrast images of colonies. The
eHBs can arise as domed colonies (left and middle images) and/or scattered colonies (right image). White bars represent 100 mm. (B)
Quantification of domed and/or scattered eHB colonies. Results are the average ± SD of three independent experiments.
(C–E and G) FACS analysis of endothelial (C and D), blood (E), and smooth muscle (G) cells arising from the eHBs, differentiated as
described in Figures 1 and 2. The results from three independent lines, each established from a single colony derived from FL or MEF cells,
are shown for every assay (each line tested once), except for (G), which shows results from only two MEF-eHB lines because the third
repeatedly failed to produce sufficient live differentiated cells for analysis.
(F) Hematopoietic CFUs from the indicated eHB lines. Results are from one (FL lines) or two (MEF lines, average ± SD shown) independent
experiments.
The eHB lines were induced and maintained with doxycycline in N2B27 medium supplemented with FGF2. See also Figure S2 for additional
data including example FACS dot plots, histograms, and images of hematopoietic colonies and Table S1.
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cell type for comparison because it is a well-defined popu-
lation of early hematopoietic progenitors (Kent et al.,
2009). The KDR+ mesoderm cells were obtained by
differentiating ESCs 4 days as described in Figure 1A. The
eHB-derived cells analyzed included the hematopoietic
populationsCDH5+/CD45 andCDH5+/CD45+ (differenti-
ated 2 or 3 days, respectively, as described in Figure 2D) and
endothelial cells (differentiated 3 days as described in
Figure 2A). When the transcriptomes of these populationsStem Cell Repwere compared by principal component analysis (Fig-
ure 4A) or unsupervised hierarchical clustering (Figure 4B),
a clear tendency was revealed. The eHBs grouped near ESC-
derived KDR+ mesoderm cells and away from ESCs. The
endothelial progeny of the eHBs grouped with the primary
endothelial cells; the blood progeny of the eHBs grouped
with FL HSCs. These data suggested the eHBs are trapped
at or downstream of mesoderm development.
The examination of keymarker genes further pinpointed
the developmental state of the eHBs. In agreement withorts j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 The Authors 1049
Figure 4. RNA-Seq Uncovers the Developmental State of the eHBs
(A) Principal component analysis.
(B) Unsupervised hierarchical clustering.
(C–F) Expression levels of select marker genes measured by RNA-seq. The y axes are in log10 scaling with a threshold of detection cutoff of 1
transcript per million (TPM). Box sizes represent the minimum to maximum TPM values of the samples described in (A) and (B); the line
inside the boxes represents the mean. (C) ESC markers. (D) Mesoderm markers. (E) Hematopoietic markers. (F) Endothelial markers.
RNA-seq analysis was performed on ESCs and their derivatives, on eHBs and their derivatives, on primary E14.5 FL HSCs, and on primary E11.5
endothelial cells (ECs). Five eHB lines were employed, two derived from ESCs, two derived from FL cells, and one derived from MEFs. See also
Figure S3 and Table S1.
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Sox2 are not expressed in the eHBs, and Nanog is poorly
detected (Figure 4C). The eHBs express a number of genes
associated with mesoderm (Figure S3A), but do not express
the transiently expressedmesoderm regulator T (Brachyury)
or Etv2 (Er71) (Figure 4D), a mesoderm factor expressed
concomitantly with T that is required for the formation
of the endothelial and hematopoietic lineages, in part by
upregulating Kdr (Flk1) (Lee et al., 2008). Kdr is inefficiently
expressed in eHBs (Figure 4D), and the several lines tested
by fluorescence-activated cell sorting (FACS) do not
robustly stain for this marker (data not shown). The down-
regulation of Kdr is likely due to the ectopic expression of
Sox17, as has been previously observed (Nakajima-Takagi
et al., 2013). This notion is supported by the observation
that Kdr expression increases in the endothelial or hemo-
genic endothelial (CDH5+/CD45) progeny of the eHBs,
as the ectopic expression of Sox17 diminishes (Figures 4D
and S3B). These data indicate that eHBs are developmen-
tally trapped downstream of T and Etv2 expression and
thus do not resemble early, canonical blast colony-forming
cells (BL-CFCs) (Choi et al., 1998; Faloon et al., 2000; Feh-
ling et al., 2003; Huber et al., 2004).
The blood or endothelial derivatives of eHBs express a
number of hematopoietic and endothelial markers (Figures
4E, 4F, S3B, and S3C). However, while the emerging blood
cells generated from the eHBs express Erg, they fail to ex-
pressHoxa9 and Rora (Figure S3C). Collectively, these three
factors have been previously shown to expand human
blood progenitors with high CFU potential (Doulatov
et al., 2013). The absence of Hoxa9 and Rora provides
a possible explanation for why the eHBs generate CFUs
poorly (Figures 3F and S1I). The blood derivatives of
the eHBs poorly express the definitive hematopoietic
progenitor markers Kit, Ly6a (Sca1), or Procr (Epcr) (Figures
4E and 4F), an additional indication that the eHBs preferen-
tially give rise to primitive hematopoiesis. The endothelial
progeny of the eHBs better express these three markers,
suggesting they may possess hemogenic potential,
although this has not been observed. The endothelial prog-
eny of the eHBs do not efficiently express the endothelial
marker VWF (Figure 4F); however, this marker has variable
expression across the developing murine vasculature
(Coffin et al., 1991). The CDH5+/CD45 progeny of the
eHBs upregulate a number of endothelial genes whose
expression then tends to diminish as the cells acquire
CD45 expression (Figures 4D and 4F), further supporting
the transiently endothelial-like nature of these cells.
A Central Role for FGF
Because eHBs are trapped in a progenitor state, they afford
the unique opportunity to examine growth factor signaling
on a hemangioblast state prior to its commitment toStem Cell Repa particular fate. The ESC-derived eHBs were originally
found and maintained with doxycycline in Vm (N2B27
medium supplemented with the growth factors BMP4,
FGF2, VEGF, and the small molecules SB431542 and
Br-cAMP). In these conditions, the cells associate loosely,
migrate as single cells or small groups (‘‘scatter’’), and at
higher densities form flatter colonies with occasional
domed colonies (Figure 5A; Movie S1). The morphology of
the cells changes as theymove: the cells elongate, contract,
and often exhibit pronounced lamellipodia. In Vm with
doxycycline, the cell populations double on average every
16 hr (Figure 5B). In N2B27 medium containing doxycy-
cline without any additional growth factors, the doubling
slowed to an average of every 37 hr, and the cells converted
togrowth indomedcolonies, reminiscentofhowtheyoften
emerge prior to passaging (‘‘No GFs’’ Figures 5A and 5B;
Movie S2). These observations indicated that one or more
of the exogenous factors present in Vm were responsible
for stimulating the eHBs to change their growth and
morphological characteristics. To determinewhich factor(s)
might be responsible, eHBs were maintained with doxycy-
cline in N2B27 medium supplemented with single addi-
tional growth factors. In contrast to the addition of BMP4,
the addition of FGF2 alone was sufficient to cause the cells
to expand more efficiently, to scatter, and to form flatter
colonies (Figures 5A and 5B; Movie S3). The ability of
FGF2 to exert these effects was not appreciably altered by
the additional presence of BMP4 (Figures 5A and 5B).
To determine the means by which FGF2 was altering the
growth and morphological characteristics of the eHBs,
small molecule inhibitors were employed. For these assays,
each inhibitor was titrated on the cells growing in N2B27
medium containing doxycycline and FGF2. In a dose-
dependent manner, PD173074, a high-affinity inhibitor
of the FGF receptor, phenocopied the absence of FGF2
(Figures 5C and 5D), indicating that FGF2 signals through
its canonical receptors. The FGF receptors target multiple
signaling pathways, including the MAPK/ERK or PI3K
pathways (reviewed in Eswarakumar et al., 2005). Indeed,
the MEK (ERK kinase) inhibitors PD0325901 and U0126,
or the PI3K inhibitor PI828, all revealed a dose-dependent
inhibition on the expansion of the eHBs (Figure 5C). How-
ever, each of these three inhibitors alone could not fully
mimic the morphological changes that occur in the
absence of FGF2 (Figure 5D). Instead, the dual inhibition
of the MEK and PI3K pathways better imitated the loss of
FGF2 (less sowithU0126,markedlywith the higher affinity
MEK inhibitor PD0325901) in the eHB line RB3.6.5.
Furthermore, the PI3K activator 740 Y-P alone failed to pro-
mote the expansion of the eHBs in the absence of FGF2
(Figure 5E), supporting the notion that FGF2 exerts its
effects on the eHBs through both MEK and PI3K signaling.
It is not yet clear whether FGF2 activates additionalorts j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 The Authors 1051
Figure 5. The Effect of FGF on the eHBs
(A) Phase contrast example images of the eHB line RB3.6.5 in different maintenance media. White bars represent 100 mm.
(B) Growth curve of eHB lines in different maintenance media.
(C) Titration of small molecule inhibitors in N2B27 medium containing doxycycline and FGF2.
(D) Phase contrast example images of the eHB line RB3.6.5 grown in medium as (C) for 2 days in the presence of the indicated small
molecule inhibitors. White bars represent 100 mm.
(legend continued on next page)
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Figure 6. Proposed Model for the Role of FGF in the eHBs
The binding of FGF to its receptor(s) (Plotnikov et al., 1999) ap-
pears to foster signaling in the eHBs through at least the MEK and
PI3K signaling pathways. Perhaps collectively, these pathways (1)
alter the morphology and migration of the eHBs, (2) cause the eHBs
to expand efficiently, and (3) prime the eHBs to generate endo-
thelial cells and leukocytes. The small molecule inhibitors em-
ployed in this study and their targets are depicted.
Stem Cell Reports
An Expandable, Inducible Hemangioblast Statesignaling pathways in the eHBs, for example, the protein
kinase C pathway (Eswarakumar et al., 2005).
We wondered if, besides altering the proliferation and
morphology of the eHBs, FGF2 might also be altering their
fate decisions. Therefore, four independent eHB cell lines
were tested for their ability to produce endothelial cells
(Figures 5F and 5G), leukocytes (scored broadly as CD45+
cells; Figure 5H), and erythrocytes (Figures 5I and 5J) after
beingmaintained in the absence or presence of FGF2. Cells
maintained only in N2B27 medium with doxycycline
tended to produce endothelial cells or leukocytes poorly.
In contrast, cells additionally supplemented with FGF2
were better able to generate these cell types. This trend
did not hold for the production of erythrocytes (Figures
5I and 5J). FGF2 did not consistently improve the efficiency
by which the eHBs produced these cells; in fact, in
some lines, the absence of FGF correlated with improved(E) Growth in N2B27 medium containing doxycycline, with or withou
(F–I) FACS analysis of the differentiated progeny from four indepen
average is shown) maintained in N2B27 medium containing doxycycl
in Figures 1 or 2. (F and G) Endothelial differentiation. (F) Endothelia
(I) The erythrocyte marker TER119.
(J) Measurements by quantitative PCR of the expression level of embry
in (I). The y axis is on a log10 scale.
Results are from eHB cell lines maintained with doxycycline in N2B27
BMP4, both FGF2 and BMP4, or Vm. (B, C, and E) Box sizes represent th
measured at the indicated times in four to five independent eHB line
the mean. Two ESC-derived eHBs and two or three FL-derived eHBs w
Stem Cell Reperythropoiesis (and improved viability of the differentiated
cells, data not shown), a finding consistent with previous
observations (Weng and Sheng, 2014). Taken together,
these data indicate that FGF2 signaling is a key influence
on the eHBs, promoting their expansion, altering their
morphology, and poising them for vasculogenesis and
leukopoiesis but not erythropoiesis.DISCUSSION
Wehave uncovered a set of six transcription factors,Gata2,
Lmo2,Mycn, Pitx2, Sox17, and Tal1, that collectively main-
tain cells in culture with the ability to give rise to blood,
endothelial, or smooth muscle progeny. In the continued
presence of the transcription factor(s), the progenitor
populations expand over many generations and commit
to a differentiation program as the ectopic factor(s) are
downregulated by the withdrawal of doxycycline. We hy-
pothesize the ability of the eHBs to remain in a proliferative
progenitor state is a result of the enduring expression of
Mycn and Sox17 because these two factors are central for
colony formation. The loss of Sox17 disrupts hematopoiesis
in the yolk sac and, more profoundly, within the embryo
(Kim et al., 2007). Recently, the transient, enforced expres-
sion of Sox17 has been found to expand a hemogenic
endothelial population that gives rise to multilineage he-
matopoietic cells (Clarke et al., 2013; Nakajima-Takagi
et al., 2013). This activity is thought to occur through the
Notch signaling pathway. Notch signaling also regulates
Myc in murine hematopoietic progenitors (Satoh et al.,
2004), but to our knowledge, it is unknown whether it
likewise regulates Mycn. However, given the parallel func-
tions of Myc and Mycn (Malynn et al., 2000), these data
suggest the hemangioblast state might in part be main-
tained by persistent Notch signaling. Both Mycn and
Sox17 are employed repeatedly during development, and
it is thus no surprise that they apparently are not enough,
on their own, to maintain a hemangioblast state. This
task, we hypothesize, is aided by the other four factors.
Indeed, Gata2, Lmo2, or Tal1 null embryos all die early
in development with extreme hematopoietic deficienciest the PI3K activator 740 Y-P (Tocris).
dent eHB lines (each line tested at least once, for replicates the
ine, with or without FGF2. Differentiated and scored as exemplified
l markers. (G) Ac-LDL uptake. (H) The pan-leukocyte marker CD45.
onic (Hbb-bh1) and adult hemoglobin (Hbb-b1) in cultures described
medium (‘‘No GFs’’) or in N2B27 medium supplemented with FGF2,
e minimum to maximum number of cumulative population doublings
s (each tested at least once); the line inside the boxes represents
ere employed. See also Table S1 and Movies S1, S2, and S3.
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1994). Ectopic Lmo2, in concert with Mycn, Hlf, Meis1,
Pbx1, Prdm5, Runx1t1, and Zfp37, has recently been shown
to reprogram blood cells to definitive HSCs (Riddell et al.,
2014). Ectopic Gata2, Tal1, and Etv2 promote the develop-
ment of murine hemangioblasts, although it is not clear
whether this combination of factors can sustain the expan-
sion of the cells, or induce them from sources other than
ESCs (Liu et al., 2013).The expression of Pitx2 is specific
to HSCs when compared with differentiated blood cells
(Degar et al., 2001), and Pitx2 null embryos die early with
a number of developmental defects (Lin et al., 1999;
Lu et al., 1999). However, Pitx2 null HSCs do arise and
give rise to differentiated blood progeny (Zhang et al.,
2006), likely indicating some functional redundancy for
this factor’s participation in hematopoiesis in vivo.
We exploited the fact that the eHBs were trapped as pro-
genitors to analyze the effect of specific growth factors
upon them and uncovered a central role for FGF (Figure 6).
These data are consistent with studies in which FGF pro-
moted the expansion of BL-CFCs derived from human or
murine ESCs (Faloon et al., 2000; Vodyanik et al., 2010)
and high proliferative potential hemangioblasts from the
murine AGM (Yao et al., 2007). The eHBs provide a trac-
table means to study in fine detail the function of FGF or
any other growth factors on the development of the blood
and blood vessel lineages.
Our study parallels the work of other groups who have
demonstrated the capacity of ectopic factors to expand pro-
genitors in vitro; for example, HOXB4 or Myc have been
used to briefly propagatemurine hematopoietic progenitors
(Satoh et al., 2004; Sauvageau et al., 1995). More recent ex-
amples include employing BCL-XL, BMI1, and MYC to
expand human megakaryocyte progenitors (Nakamura
et al., 2014); Myc, Sox2, and an shRNA targeting p53 to
expand human erythroid progenitors (Huang et al., 2014);
and ERG,HOXA9,MYB, RORA, and SOX4 to expand human
hematopoietic progenitors withmultilineage potential that
can transiently give rise to erythroid ormyeloid cells in vivo
(Doulatov et al., 2013). The ability to efficiently expand
progenitors has broad implications; by identifying the
‘‘resident’’ proto-oncogenes in a given progenitor cell and
then controlling them ectopically, it may be possible to
trap, expand, and study many other types of progenitor
cells and their differentiated progeny, particularly those
that are not currently able to be maintained in culture.EXPERIMENTAL PROCEDURES
Mice Strains
The following strains of mice were employed: B6.SJL-Ptprca
Pepcb/BoyJ (Jackson, stock number 002014) and B6.Cg-Gt(ROSA)
26Sortm1(rtTA*M2)Jae/J (Jackson, stock number 006965). Animal ex-1054 Stem Cell Reports j Vol. 3 j 1043–1057 j December 9, 2014 j ª2014 Thperiments and procedures were approved by the University of
Wisconsin-Madison School of Medicine and Public Health Animal
Care and Use Committee and were conducted in accordance
with the Animal Welfare Act and Health Research Extension Act.
DNAVectors
The cDNAs for rat Gata2 and murine Lmo2, Tal1, Sox17, Mycn,
Pitx2, Hoxb5, and Rbp1 were obtained from Open Biosystems or
GeneCopoeia encoded on Gateway Entry vectors or subsequently
cloned into them. The sequence encodingmiR-130awas amplified
by PCR from murine genomic DNA and cloned into a Gateway
Entry vector. All cDNAs on Entry vectors were then cloned, using
Gateway LR clonase (Life Technologies), into a doxycycline-
inducible expression cassette akin to a previously reported
construction (Agha-Mohammadi et al., 2004) flanked by PiggyBac
terminal repeats on a Gateway Destination vector. All vectors and
their sequences are available upon request.
Isolation, Culture, and Cryopreservation of eHBs
Colonies were picked under a dissecting microscope 5 to 8 days
(depending on the starting cell type) after induction with 2 mg/ml
doxycycline and dissociated by incubation in HEH (0.5 mM
EDTA [Fisher] in 1 3 Hank’s balanced salt solution supplemented
with 10 mM HEPES [both from Life Technologies]) for 5 to
10 min followed by trituration. Cells were pelleted and plated on
Matrigel-coated plasticware in medium containing doxycycline.
For each passage, typically every 2 days, cells were dissociated
with HEH and replated, unless otherwise noted. Karyotype
analyses were conducted at the WiCell Research Institute. To
efficiently cryopreserve the eHBs, cells were resuspended in
N2B27 medium and aliquoted to cyrotubes containing an equal
volume of N2B27 medium with 10% DMSO (Sigma), for a final
concentration of 5% DMSO, and gently inverted repeatedly to
mix. The tubes were frozen in Nalgene ‘‘Mr. Frosty’’ freezing
containers at 80C and then placed in liquid nitrogen. Upon
thawing rapidly in a 37C water bath, cells were removed from
tubes using large orifice tips, diluted into N2B27 medium, and
pelleted to remove DMSO. All cell lines were cultured at 37C
and 5% CO2 in humidified incubators.
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